生物活性
CHIR-98014是一种非常有效的,选择性的,细胞可渗透的GSK-3抑制剂。
Targets
Target | Value |
GSK-3β | IC50: 0.58nM |
GSK-3α | IC50: 0.65nM |
p70S6K | IC50: >1μM |
c-Src | IC50: >1μM |
bFGFR | IC50: >1μM |
KDR | IC50: >2μM |
IGF-1R | IC50: >2μM |
Insulin Receptor | IC50: >2μM |
Cdc2 | IC50: 3.7μM |
Akt1 | IC50: >5μM |
Tie-2 | IC50: >5μM |
FLT1 | IC50: >5μM |
CK1ε | IC50: >5μM |
ERK2 | IC50: >10μM |
PKCα | IC50: >10μM |
p90RSK2 | IC50: >10μM |
Chk1 | IC50: >10μM |
DNA-PK | IC50: >10μM |
PI3K | IC50: >10μM |
化学数据
目录号 | A11085 |
作用机制 | Inhibitor (抑制剂) |
M. Wt | 486.3 |
Formula | C20H17Cl2N9O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for36 months. In solution, store at -20ºC and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
CAS No. | 252935-94-7 |
Synonyms | CHIR98014 |
SMILES | C1=CC(=C(C=C1Cl)Cl)C2=NC(=NC=C2N3C=CN=C3)NCCNC4=NC(=C(C=C4)[N+](=O)[O-])N |
溶解度
In vitro (25°C) | DMSO | Warmed: 7 mg/mL (14.39 mM) |
Water | Insoluble |
Ethanol | Insoluble |
In vivo | 5% DMSO+corn oil | 1 mg/mL |
*<1 mg/ml means slightly soluble or insoluble. *Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
0.1 mM | 20.56 mL | 102.82 mL | 205.63 mL |
0.5 mM | 4.11 mL | 20.56 mL | 41.13 mL |
1 mM | 2.06 mL | 10.28 mL | 20.56 mL |
5 mM | 0.41 mL | 2.06 mL | 4.11 mL |
*The above data is based on the productmolecular weight 486.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.